HRT Financial’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-110,242
| Closed | -$113K | – | 2413 |
|
|
2024
Q4 | $113K | Buy |
110,242
+83,402
| +311% | +$85.5K | ﹤0.01% | 1825 |
|
|
2024
Q3 | $31K | Buy |
+26,840
| New | +$31K | ﹤0.01% | 1980 |
|
|
2024
Q2 | – | Sell |
-16,831
| Closed | -$36K | – | 2184 |
|
|
2024
Q1 | $36K | Buy |
+16,831
| New | +$36K | ﹤0.01% | 1851 |
|
|
2022
Q2 | – | Sell |
-68,259
| Closed | -$182K | – | 2932 |
|
|
2022
Q1 | $182K | Sell |
68,259
-75,901
| -53% | -$202K | ﹤0.01% | 2255 |
|
|
2021
Q4 | $624K | Sell |
144,160
-5,016
| -3% | -$21.7K | ﹤0.01% | 1398 |
|
|
2021
Q3 | $759K | Buy |
+149,176
| New | +$759K | ﹤0.01% | 1398 |
|
|
2021
Q1 | – | Sell |
-27,640
| Closed | -$181K | – | 2536 |
|
|
2020
Q4 | $181K | Buy |
27,640
+5,382
| +24% | +$35.2K | ﹤0.01% | 1443 |
|
|
2020
Q3 | $148K | Buy |
+22,258
| New | +$148K | ﹤0.01% | 1361 |
|
|
2020
Q1 | – | Sell |
-18,478
| Closed | -$153K | – | 737 |
|
|
2019
Q4 | $153K | Buy |
+18,478
| New | +$153K | 0.01% | 930 |
|